Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Robert G. Nelson, MD, PhD"'
Autor:
Robin L. Baudier, Paula F. Orlandi, Wei Yang, Hsiang-Yu Chen, Nisha Bansal, J. Walker Blackston, Jing Chen, Rajat Deo, Mirela Dobre, Hua He, Jiang He, Ana C. Ricardo, Tariq Shafi, Anand Srivastava, Dawei Xie, Katalin Susztak, Harold I. Feldman, Amanda H. Anderson, Lawrence J. Appel, MD, Debbie Cohen, MD, Laura Dember, MD, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, Mark L. Unruh, MD
Publikováno v:
Kidney Medicine, Vol 6, Iss 8, Pp 100850- (2024)
Rationale & Objective: Matrix metalloproteinase 2 (MMP-2) plays an important role in the development of fibrosis, the final common pathway of chronic kidney disease (CKD). This study aimed to assess the relationship between repeated measures of MMP-2
Externí odkaz:
https://doaj.org/article/252319ba1a8a4904a23462feb4c12231
Autor:
Rosalba Hernandez, Dawei Xie, Xue Wang, Neil Jordan, Ana C. Ricardo, Amanda H. Anderson, Clarissa J. Diamantidis, John W. Kusek, Kristine Yaffe, James P. Lash, Michael J. Fischer, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Publikováno v:
Kidney Medicine, Vol 6, Iss 4, Pp 100790- (2024)
Rationale & Objective: The extent to which depression affects the progression of chronic kidney disease (CKD) and leads to adverse clinical outcomes remains inadequately understood. We examined the association of depressive symptoms (DS) and antidepr
Externí odkaz:
https://doaj.org/article/372492a36bc0499d8b10263e02f5ba88
Autor:
David M. Charytan, Wenbo Wu, Mengling Liu, Zhong-Min Li, Kurunthachalam Kannan, Leonardo Trasande, Vineet Kumar Pal, Sunmi Lee, Howard Trachtman, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS.
Publikováno v:
Kidney Medicine, Vol 6, Iss 3, Pp 100778- (2024)
Rationale & Objective: This study aimed to assess the effect of exposure to organic pollutants in adults with chronic kidney disease (CKD). Study Design: This was a cross-sectional and longitudinal analysis. Setting and Participants: Forty adults enr
Externí odkaz:
https://doaj.org/article/4494229931ba4c97a2a8fd14827f7568
Autor:
Alexander S. Leidner, Xuan Cai, Leila R. Zelnick, Jungwha Lee, Nisha Bansal, Andreas Pasch, Mayank Kansal, Jing Chen, Amanda Hyre Anderson, James H. Sondheimer, James P. Lash, Raymond R. Townsend, Alan S. Go, Harold I. Feldman, Sanjiv J. Shah, Myles Wolf, Tamara Isakova, Rupal C. Mehta, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Publikováno v:
Kidney Medicine, Vol 5, Iss 11, Pp 100723- (2023)
Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical studies implicates excess levels of fibroblast grow
Externí odkaz:
https://doaj.org/article/8c1713b6e8d342b98764f7e852bba1ef
Autor:
Jonathan J. Taliercio, Georges Nakhoul, Ali Mehdi, Wei Yang, Daohang Sha, Jesse D. Schold, Scott Kasner, Matthew Weir, Mohamed Hassanein, Sankar D. Navaneethan, Geetha Krishnan, Radhika Kanthety, Alan S. Go, Rajat Deo, Claudia M. Lora, Bernard G. Jaar, Teresa K. Chen, Jing Chen, Jiang He, Mahboob Rahman, Lawrence J. Appel, MD, MPH, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Publikováno v:
Kidney Medicine, Vol 4, Iss 11, Pp 100547- (2022)
Rationale and Objective: Chronic kidney disease is a risk enhancing factor for cardiovascular disease (CVD) and mortality, and the role of aspirin use is unclear in this population. We investigated the risk and benefits of aspirin use in primary and
Externí odkaz:
https://doaj.org/article/ff51643bfe34488d907e02835f2ed474
Autor:
Lahens NF; Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Rahman M; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA., Cohen JB; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Cohen DL; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Chen J; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Weir MR; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Feldman HI; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Grant GR; Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Townsend RR; Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Skarke C; Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Study Investigators ATC; Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Lawrence J. Appel, MD, MPH, Alan S. Go, MD, Jiang He, MD, PhD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, and Mark L. Unruh, MD, MS.
Publikováno v:
Digital health [Digit Health] 2022 Jun 16; Vol. 8, pp. 20552076221107903. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).